Placebo to alogliptin

DRUG2 trials

Sponsors

Takeda, AstraZeneca

Conditions

Diabetes Mellitus, Type 2Type 2 Diabetes

Phase 1

Roflumilast Plus Alogliptin Proof-of-Mechanism Study in Type2 Diabetes

CompletedNCT01664624

AstraZenecaType 2 Diabetes

Start: 2012-07-31End: 2012-11-30Updated: 2017-02-01

Phase 3

Efficacy and Safety of Alogliptin in Participants With Type 2 Diabetes

CompletedNCT01289119

TakedaDiabetes Mellitus, Type 2

Start: 2010-12-31End: 2011-12-31Updated: 2013-03-22